| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.4M | -87.9% |
| R&D Expense | $142.3M | +13.5% |
| SG&A Expense | $41.0M | +6.7% |
| Operating Income | -$157.9M | -435.9% |
| Income Tax | $924K | +7.6% |
| Net Income | -$143.8M | -319.0% |
| EPS (Basic) | -$3.47 | -297.2% |
| EPS (Diluted) | -$3.47 | -306.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.4M | -10.7% |
| Current Assets | $306.3M | -30.4% |
| Total Assets | $377.4M | -28.3% |
| Current Liabilities | $24.5M | -38.1% |
| Total Liabilities | $71.2M | -27.0% |
| Stockholders' Equity | $306.1M | -28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$128.5M | -209.2% |
| Capital Expenditures | $1.0M | -67.0% |
| Investing Cash Flow | $116.8M | +520.2% |
| Financing Cash Flow | $887K | -99.1% |
| Free Cash Flow | -$129.6M | -189.7% |